172 related articles for article (PubMed ID: 18186109)
1. Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease.
Eri R; Kodumudi KN; Summerlin DJ; Srinivasan M
Inflamm Bowel Dis; 2008 Apr; 14(4):458-70. PubMed ID: 18186109
[TBL] [Abstract][Full Text] [Related]
2. Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent.
Srinivasan M; Eri R; Zunt SL; Summerlin DJ; Brand DD; Blum JS
Arthritis Rheum; 2007 Feb; 56(2):498-508. PubMed ID: 17265485
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the colonic epithelial cell responses and amelioration of inflammation by CD80 blockade in TNBS colitis.
Srinivasan M; Summerlin DJ
Clin Immunol; 2009 Dec; 133(3):411-21. PubMed ID: 19811954
[TBL] [Abstract][Full Text] [Related]
4. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
[TBL] [Abstract][Full Text] [Related]
5. CD80 blockade enhance glucocorticoid-induced leucine zipper expression and suppress experimental autoimmune encephalomyelitis.
Dudhgaonkar SP; Janardhanam SB; Kodumudi KN; Srinivasan M
J Immunol; 2009 Dec; 183(11):7505-13. PubMed ID: 19917693
[TBL] [Abstract][Full Text] [Related]
6. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
7. CD80 binding polyproline helical peptide inhibits T cell activation.
Srinivasan M; Lu D; Eri R; Brand DD; Haque A; Blum JS
J Biol Chem; 2005 Mar; 280(11):10149-55. PubMed ID: 15598660
[TBL] [Abstract][Full Text] [Related]
8. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
9. T-cell co-stimulatory molecules are upregulated on intestinal macrophages from inflammatory bowel disease mucosa.
Rogler G; Hausmann M; Spöttl T; Vogl D; Aschenbrenner E; Andus T; Falk W; Schölmerich J; Gross V
Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1105-11. PubMed ID: 10524639
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.
Philippe D; Dubuquoy L; Groux H; Brun V; Chuoï-Mariot MT; Gaveriaux-Ruff C; Colombel JF; Kieffer BL; Desreumaux P
J Clin Invest; 2003 May; 111(9):1329-38. PubMed ID: 12727924
[TBL] [Abstract][Full Text] [Related]
11. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
[TBL] [Abstract][Full Text] [Related]
12. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
[TBL] [Abstract][Full Text] [Related]
13. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model.
Van Montfrans C; Rodriguez Pena MS; Pronk I; Ten Kate FJ; Te Velde AA; Van Deventer SJ
Gastroenterology; 2002 Dec; 123(6):1865-76. PubMed ID: 12454844
[TBL] [Abstract][Full Text] [Related]
14. Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD.
Liu H; Dasgupta S; Fu Y; Bailey B; Roy C; Lightcap E; Faustin B
BMC Immunol; 2019 Nov; 20(1):42. PubMed ID: 31718550
[TBL] [Abstract][Full Text] [Related]
15. Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis.
Totsuka T; Kanai T; Iiyama R; Uraushihara K; Yamazaki M; Okamoto R; Hibi T; Tezuka K; Azuma M; Akiba H; Yagita H; Okumura K; Watanabe M
Gastroenterology; 2003 Feb; 124(2):410-21. PubMed ID: 12557147
[TBL] [Abstract][Full Text] [Related]
16. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
[TBL] [Abstract][Full Text] [Related]
17. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
[TBL] [Abstract][Full Text] [Related]
18. Blocking inducible co-stimulator in the absence of CD28 impairs Th1 and CD25+ regulatory T cells in murine colitis.
de Jong YP; Rietdijk ST; Faubion WA; Abadia-Molina AC; Clarke K; Mizoguchi E; Tian J; Delaney T; Manning S; Gutierrez-Ramos JC; Bhan AK; Coyle AJ; Terhorst C
Int Immunol; 2004 Feb; 16(2):205-13. PubMed ID: 14734605
[TBL] [Abstract][Full Text] [Related]
19. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
20. Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis.
Zuo L; Huang Z; Dong L; Xu L; Zhu Y; Zeng K; Zhang C; Chen J; Zhang J
Gut; 2010 Apr; 59(4):470-9. PubMed ID: 19951904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
